Company / Operating Income per Share
Moleculin Biotech, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$197.11
FY2025
5-year range
-$197.11 / -$1.71
FY2021-FY2025
Trend
-1381.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -1382% YoY in FY2025, a notable deviation from the 8-year average annual change of -345%.
Based on SEC 10-K filings.
-197.11 in FY2025.
Declined from $-16.05 to $-197.11 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 1381.8% year-over-year.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$197.11 | -1381.8% |
| FY2024 | -$13.30 | +17.1% |
| FY2023 | -$16.05 | - |
| FY2022 | - | - |
| FY2021 | -$1.71 | +25.6% |
| FY2020 | -$2.30 | -336.6% |
| FY2019 | -$0.53 | -30.7% |
| FY2018 | -$0.40 | -26.3% |
| FY2017 | -$0.32 | -188.0% |
| FY2016 | -$0.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026